Dr Agarwals Eye Hospital Ltd

Dr Agarwal's Eye Summary Chart Analysis Peers Quarters Profit & Loss Balance Sheet Cash Flow Ratios Investors Documents

Dr Agarwals Eye Hospital Ltd

₹ 5,605 2.71%
13 Dec - close price
dragarwal.com BSE: 526783
About

Dr Agarwal's Eye Hospital Ltd is a leading chain of eye hospitals with predominant presence in Tamil Nadu.[1]

Key Points

Services Offered
The company's centers offer comprehensive services in the eye-care segment including cataract, glaucoma, laser correction, corner and refractive, retina, squint, etc. [1]

Website BSE
  • Market Cap ₹ 2,634 Cr.
  • Current Price ₹ 5,605
  • High / Low ₹ 5,759 / 2,542
  • Stock P/E 52.2
  • Book Value ₹ 392
  • Dividend Yield 0.09 %
  • ROCE 18.4 %
  • ROE 34.4 %
  • Face Value ₹ 10.0
Edit ratios

Pros

  • Company has delivered good profit growth of 31.4% CAGR over last 5 years
  • Company has a good return on equity (ROE) track record: 3 Years ROE 36.1%

Cons

  • Stock is trading at 14.3 times its book value
  • Company might be capitalizing the interest cost
  • Promoters have pledged 55.4% of their holding.

* The pros and cons are machine generated. Pros / cons are based on a checklist to highlight important points. Please exercise caution and do your own analysis.

Peer comparison

Sector: Healthcare Industry: Healthcare

Edit Columns
Loading peers table ...

Quarterly Results

Figures in Rs. Crores

Sep 2021 Dec 2021 Mar 2022 Jun 2022 Sep 2022 Dec 2022 Mar 2023 Jun 2023 Sep 2023 Dec 2023 Mar 2024 Jun 2024 Sep 2024
58 56 56 66 69 64 69 79 84 76 81 100 102
39 40 39 47 50 48 48 56 61 55 56 69 72
Operating Profit 19 17 16 20 19 15 21 23 23 21 24 31 30
OPM % 33% 30% 29% 30% 27% 24% 30% 29% 28% 27% 30% 31% 29%
0 0 0 0 1 0 0 0 1 1 2 0 2
Interest 2 2 2 2 1 2 2 2 2 2 2 3 4
Depreciation 5 5 6 6 6 7 2 6 6 7 8 10 9
Profit before tax 13 11 9 12 12 7 18 16 17 13 17 19 19
Tax % 25% 25% 26% 25% 27% 24% 25% 26% 24% 26% 26% 25% 26%
10 8 7 9 9 5 14 12 13 9 13 14 14
EPS in Rs 20.87 17.34 14.62 19.38 19.30 10.77 29.11 24.55 26.79 20.09 27.21 30.02 30.11
Raw PDF

Profit & Loss

Figures in Rs. Crores

Mar 2013 Mar 2014 Mar 2015 Mar 2016 Mar 2017 Mar 2018 Mar 2019 Mar 2020 Mar 2021 Mar 2022 Mar 2023 Mar 2024 TTM
109 113 118 137 149 153 170 176 140 201 268 319 359
96 102 103 119 126 129 140 129 109 143 192 227 252
Operating Profit 12 11 15 18 23 24 30 47 31 59 76 92 106
OPM % 11% 9% 13% 13% 15% 16% 18% 27% 22% 29% 28% 29% 30%
1 3 0 -5 1 2 2 3 1 1 2 5 6
Interest 4 4 4 5 4 3 4 9 7 7 8 8 11
Depreciation 5 6 6 9 9 10 11 21 19 20 20 27 34
Profit before tax 4 4 5 -0 11 13 17 20 6 32 49 62 68
Tax % 29% 35% -6% -104% 33% 49% 32% 31% 125% 25% 25% 26%
3 2 6 0 7 7 12 14 -1 24 37 46 50
EPS in Rs 6.98 5.17 12.13 0.09 15.62 14.43 25.36 29.11 -3.06 51.28 78.55 98.64 107.43
Dividend Payout % 17% 23% 10% 940% 10% 8% 6% 0% 0% 6% 4% 3%
Compounded Sales Growth
10 Years: 11%
5 Years: 13%
3 Years: 32%
TTM: 21%
Compounded Profit Growth
10 Years: 34%
5 Years: 31%
3 Years: 226%
TTM: 18%
Stock Price CAGR
10 Years: 44%
5 Years: 84%
3 Years: 93%
1 Year: 107%
Return on Equity
10 Years: 28%
5 Years: 30%
3 Years: 36%
Last Year: 34%

Balance Sheet

Figures in Rs. Crores

Mar 2013 Mar 2014 Mar 2015 Mar 2016 Mar 2017 Mar 2018 Mar 2019 Mar 2020 Mar 2021 Mar 2022 Mar 2023 Mar 2024 Sep 2024
Equity Capital 4 5 5 5 5 5 5 5 5 5 5 5 5
Reserves 11 14 19 19 25 30 41 51 50 73 109 152 179
28 28 27 31 23 18 24 60 68 193 232 268 305
19 20 18 24 20 28 31 24 33 42 44 71 80
Total Liabilities 63 67 69 79 72 81 100 141 155 314 390 496 569
23 26 26 34 33 36 55 94 96 214 260 316 364
CWIP 0 0 0 1 1 3 0 0 0 26 62 97 114
Investments 0 0 0 0 0 0 0 0 0 0 0 0 13
41 41 43 44 38 42 45 47 60 73 67 83 78
Total Assets 63 67 69 79 72 81 100 141 155 314 390 496 569

Cash Flows

Figures in Rs. Crores

Mar 2013 Mar 2014 Mar 2015 Mar 2016 Mar 2017 Mar 2018 Mar 2019 Mar 2020 Mar 2021 Mar 2022 Mar 2023 Mar 2024
11 12 14 17 20 19 25 39 34 57 70 90
-6 -11 -10 -17 -8 -11 -25 -17 -11 -46 -71 -70
-3 -3 -5 -0 -12 -8 2 -20 -8 -4 0 -14
Net Cash Flow 2 -2 -1 0 0 -0 2 2 15 7 -1 6

Ratios

Figures in Rs. Crores

Mar 2013 Mar 2014 Mar 2015 Mar 2016 Mar 2017 Mar 2018 Mar 2019 Mar 2020 Mar 2021 Mar 2022 Mar 2023 Mar 2024
Debtor Days 13 19 19 24 16 17 19 14 23 16 14 15
Inventory Days 97 96 238 200 123 148 124 132 117 91 73 106
Days Payable 138 137 360 371 277 353 292 224 401 410 327 345
Cash Conversion Cycle -27 -22 -103 -146 -138 -189 -149 -78 -260 -303 -240 -224
Working Capital Days -32 -23 -5 -23 -18 -28 -11 -6 -20 -29 -24 -40
ROCE % 19% 17% 19% 18% 29% 32% 34% 30% 11% 20% 19% 18%

Shareholding Pattern

Numbers in percentages

Dec 2021Mar 2022Jun 2022Sep 2022Dec 2022Mar 2023Jun 2023Sep 2023Dec 2023Mar 2024Jun 2024Sep 2024
72.38% 72.15% 72.00% 71.90% 71.89% 71.89% 71.89% 71.89% 71.89% 71.89% 71.90% 71.90%
0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.28% 0.63% 0.64% 0.65% 0.83%
0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.96%
27.62% 27.85% 28.00% 28.09% 28.10% 28.10% 28.10% 27.82% 27.47% 27.47% 27.46% 26.32%
No. of Shareholders 2,7412,7642,7912,8583,0063,1103,1693,4713,4233,5723,8084,510

* The classifications might have changed from Sep'2022 onwards. The new XBRL format added more details from Sep'22 onwards.

Classifications such as banks and foreign portfolio investors were not available earlier. The sudden changes in FII or DII can be because of these changes.

Click on the line-items to see the names of individual entities.

Documents

Announcements

Annual reports

Credit ratings